Fortis Healthcare releases transcript of September 4 investor call
- Fortis Healthcare released the transcript of its September 4, 2026 investor call
- Management addressed the Delhi High Court's order for a forensic audit
- IHH confirmed no impediment to strategic plans or capital infusion
- Audit scope includes examination of share dissipation by erstwhile promoters

*this image is generated using AI for illustrative purposes only.
Fortis Healthcare has published the transcript of its joint meeting with analysts and investors held on September 4, 2026. The session featured management from Fortis Healthcare and IHH Healthcare Berhad addressing recent legal developments.
Meeting details
The interaction served as a virtual group call to provide updates on the Delhi High Court's order directing a forensic audit. No unpublished price-sensitive information (UPSI) was discussed during the session.
| Parameter | Details |
|---|---|
| Date | September 4, 2026 |
| Time | 1:50 pm IST |
| Mode | Virtual Conference |
| Participants | Analysts and investors |
Such meetings serve as a structured forum for the company to engage directly with the investment community, providing an opportunity for stakeholders to seek clarity on operational matters.
Transcript access
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript is accessible via the company’s investor relations page. The event occurred on Friday, September 4, 2026, at 1:50 pm IST.
Participants who missed the live session can read the full transcript through the link provided on the official website. The audio recording was also available from September 4 to September 11, 2026, via +91 22 7194 5757 using playback ID 15861.
Historical Stock Returns for Fortis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.85% | +0.64% | -2.53% | +5.61% | -7.73% | 0.0% |
How might the findings of the Delhi High Court-mandated forensic audit impact Fortis Healthcare's future financial reporting and regulatory compliance costs?
What are the potential implications for the pending merger or strategic partnership between Fortis Healthcare and IHH Healthcare Berhad given these legal developments?
Could the ongoing legal scrutiny affect Fortis Healthcare's ability to secure new debt financing or maintain its current credit ratings in the near term?


































